If you’re a do-it-yourself investor aiming to build a “no babysitter required” portfolio, here are the key steps to take.

If you’re a do-it-yourself investor aiming to build a “no babysitter required” portfolio, here are the key steps to take.

Fresenius Kabi continues the expansion of its biosimilars portfolio in the U.S. with the introduction of Conexxence (denosumab-bnht) and Bomyntra® (denosumab-bnht) in the United States.

SHANGHAI, June 30, 2025 /PRNewswire/ -- On June 30th, Beijing time, Unisound, a pioneer in the industrialization of AI technologies in China and a portfolio company of Qiming Venture Partners, ...

/ June 26, 2025 / AstraBit has integrated a portfolio optimization engine grounded in Markowitz’s Modern Portfolio Theory (MPT) and Post-Modern Portfolio Theory (PMPT), enabling users to apply ...

NEW YORK CITY, NY / ACCESS Newswire / June 26, 2025 / AstraBit has integrated a portfolio optimization engine grounded in Markowitz's Modern Portfolio Theory (MPT) and Post-Modern Portfolio Theory ...